AKT1 and type 2 diabetes mellitus: In an experimental-computational approach, Rajan et al. [69,70] showed that reduced levels of AKT1-mediated FOXO1–S256 phosphorylation in T2D can be recapitulated by a model in which mTORC1 inhibition results in decreased FOXO1 translation.